日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
10/07/2025 | 胡兆鹏 | 1201(L) | -3,715(L) | 4,246,478(L) | 0.51 | |
10/07/2025 | 胡兆鹏 | 1711(L) | 15,000(L) | 4,250,193(L) | 0.51 | |
04/07/2025 | Liu Ye | 1711(L) | 812,625(L) | 84,251,340(L) | 10.09 | |
04/07/2025 | Morgan Stanley | 1704(L) | -25,416,628(L) | 22,289,958(L) 6,016,022(S) 0(P) | 2.67 0.72 0.00 | |
03/07/2025 | Morgan Stanley | 1312(L) | 401,500(L) | 48,260,188(L) 6,579,022(S) 0(P) | 5.78 0.78 0.00 | |
02/07/2025 | Morgan Stanley | 1013(L) | +38,205,670(L) | 48,260,188(L) 6,579,022(S) 0(P) | 5.78 0.78 0.00 | |
01/07/2025 | Suzhou Yunchang Investment Consulting Co., Ltd. (苏州蕴长投资谘询有限公司) | 1201(L) | -37,000,000(L) | 89,200,000(L) | 10.67 | |
01/07/2025 | Suzhou Fuyan Venture Capital Management Partnership (Limited Partnership) (苏州富沿创业投资管理合夥企业(有限合夥)) | 1201(L) | -25,900,000(L) | 62,440,000(L) | 7.47 | |
01/07/2025 | Suzhou Frontline BioVentures Venture Capital Fund II L.P. (苏州通和二期创业投资合夥企业(有限合夥)) | 1201(L) | -25,900,000(L) | 62,440,000(L) | 7.47 | |
01/07/2025 | 张绮苹 | 1201(L) | -37,000,000(L) | 89,200,000(L) | 10.67 | |
24/06/2025 | Liu Ye | 1113(L) | +8,138,350(L) | 84,251,340(L) | 10.09 | |
24/06/2025 | 胡兆鹏 | 12041(L) | -150,000(L) | 4,018,193(L) | 0.48 | |
24/06/2025 | 胡兆鹏 | 1113(L) | +232,000(L) | 4,250,193(L) | 0.51 | |
13/06/2025 | 胡兆鹏 | 1201(L) | -2,014(L) | 4,168,193(L) | 0.50 | |
13/06/2025 | 胡兆鹏 | 1711(L) | 10,275(L) | 4,170,207(L) | 0.50 | |
07/04/2025 | 胡兆鹏 | 1711(L) | 25,275(L) | 4,172,550(L) | 0.50 | |
07/04/2025 | 胡兆鹏 | 1201(L) | -2,343(L) | 4,170,207(L) | 0.50 | |
07/04/2025 | Liu Ye | 1711(L) | 812,625(L) | 76,112,990(L) | 9.12 | |
18/02/2025 | Liu Ye | 1316(L) | 647,000(L) | 76,112,990(L) | 9.12 | |
20/01/2025 | Liu Ye | 1316(L) | 1,319,000(L) | 76,112,990(L) | 9.12 | |
07/01/2025 | 胡兆鹏 | 1711(L) | 15,000(L) | 4,175,946(L) | 0.50 | |
07/01/2025 | 胡兆鹏 | 1201(L) | -3,396(L) | 4,172,550(L) | 0.50 | |
06/01/2025 | Liu Ye | 1711(L) | 812,625(L) | 76,112,990(L) | 9.14 | |
17/12/2024 | 胡兆鹏 | 1711(L) | 10,275(L) | 4,178,855(L) | 0.50 | |
17/12/2024 | 胡兆鹏 | 1201(L) | -2,909(L) | 4,175,946(L) | 0.60 | |
18/10/2024 | Temasek Holdings (Private) Limited | 1201(L) | -199,000(L) | HKD5.794(L) | 40,822,900(L) | 4.98 |
16/10/2024 | Boyu Capital Group Holdings Ltd | 1213(L) | 85,903,230(L) | 10.31 | ||
16/10/2024 | Boyu Capital Fund IV, L.P. | 1213(L) | 78,214,230(L) | 9.39 | ||
16/10/2024 | Boyu Capital General Partner IV, Ltd | 1213(L) | 78,214,230(L) | 9.39 | ||
16/10/2024 | Temasek Holdings (Private) Limited | 1213(L) | 41,104,400(L) | 5.01 | ||
16/10/2024 | 6 Dimensions Capital, L.P. | 1210(L) | 119,890,000(L) | 119,890,000(L) | 14.63 | |
16/10/2024 | 6 Dimensions Capital GP, LLC | 1210(L) | 126,200,000(L) | 126,200,000(L) | 15.40 | |
16/10/2024 | Suzhou 6Dimensions Venture Capital Partnership L.P. (苏州通和毓承投资合夥企业(有限合夥)) | 1210(L) | 37,860,000(L) | 37,860,000(L) | 4.62 | |
16/10/2024 | Suzhou Frontline BioVentures Venture Capital Fund II L.P. (苏州通和二期创业投资合夥企业(有限合夥)) | 1210(L) | 88,340,000(L) | 88,340,000(L) | 10.78 | |
16/10/2024 | 张绮苹 | 1210(L) | 126,200,000(L) | 126,200,000(L) | 15.40 | |
16/10/2024 | Suzhou Fuyan Venture Capital Management Partnership (Limited Partnership) (苏州富沿创业投资管理合夥企业(有限合夥)) | 1210(L) | 88,340,000(L) | 88,340,000(L) | 10.78 | |
16/10/2024 | Alcon Pharmaceuticals Ltd | 1002(L) | +139,159,664(L) | 139,159,664(L) | 16.71 | |
16/10/2024 | Alcon Inc. | 1002(L) | +139,159,664(L) | 139,159,664(L) | 16.71 | |
16/10/2024 | Suzhou Tongyu Investment Management Partnership (Limited Partnership) (苏州通毓投资管理合夥企业(有限合夥)) | 1210(L) | 37,860,000(L) | 37,860,000(L) | 4.62 | |
16/10/2024 | Suzhou Yunchang Investment Consulting Co., Ltd. (苏州蕴长投资谘询有限公司) | 1210(L) | 126,200,000(L) | 126,200,000(L) | 15.40 | |
1 2 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 23/07/2025 18:00 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |